| Particulars |
|
|
|
| Company Name
| Alembic Pharmaceuticals Ltd
| Year End
| 202403
|
| Full Year |
| Equity (₹ Cr.) |
39.31 |
B.V. (₹) |
256.00 |
| Sales(₹ Cr.) |
5,874.06 |
NP (₹ Cr.) |
665.49 |
| NP Var% |
92.00 |
Div% |
550.00 |
| CPS(₹) |
47.70 |
EPS (₹) |
33.90 |
| Traded Value(₹ Lakhs) |
107.42 |
52 Week High |
1,296.00 |
| 52 Week Low |
825.00 |
Price BSE |
1,009.00 |
| Price NSE |
1,010.00 |
Market Capital (₹ Cr.) |
19,836.17 |
| P/C Ratio |
21.20 |
P/E Ratio |
29.80 |
| Price Vs.BV |
3.94 |
|
| Latest Quarter |
| Year End |
202409 |
Sales (₹ Cr.) |
1,580.35 |
| NP(₹ Cr.) |
155.11 |
NP Var % |
16.00 |
| Trailing Twelve Months |
| Year End |
202409 |
Sales |
6,118.85 |
| OPM |
19.01 |
NP |
766.41 |
| NP Var% |
59.32 |
EPS |
38.99 |
| PE |
25.88 |
|
|